Lecture 12_Part 1

ProBurse and Biotechnology have accelerated rapidly over the past decade, with expectations of dramatic changes ahead.
Genetic modification of existing organisms and creation of new organisms is becoming inexpensive and pervasive.
Cost of DNA sequencing has significantly decreased:
- Dropped from $10,000,000 to about $500 within the past 20 years.
Improvements in genome sequencing technology have enabled the accumulation of large datasets of medical and genetic information, enhancing our understanding and ability to modify genomes.
Notable recent advances in genetic engineering include:
- CRISPR Technology:
- Allows precise targeting of specific DNA sequences and slicing of DNA strands at designated locations.
- Dramatically simplifies genetic editing compared to earlier recombinant DNA technologies.

Biotechnology remains a relatively new field with immense potential for medical advancement.
Much progress is expected from advances in personalized medicine, which tailors therapies to individual patient conditions and genetic characteristics.

Definition: GWAS is a research paradigm aimed at understanding how genetic variants relate to observable traits (phenotypes) on a genome-wide scale.
Focuses mainly on complex conditions influenced by multiple genes, in contrast to Mendelian diseases which involve a single gene.
Research process in GWAS:
- Collect genomes from a target group exhibiting a certain trait (e.g., high blood pressure) and a control group without that trait.
- Apply statistical techniques and machine learning algorithms to identify genetic variants associated with that trait.
Primary Goal: Identify associations between genetic variations and observable traits (phenotypes).
- Observable traits include conditions like diseases, physical characteristics, and other health indicators.

Data Collection:
- Sequence genomes of affected individuals (cases) and unaffected individuals (controls).
- Compare genetic differences to identify variants common in cases but rare in controls.
Essential Components:
- Genetic Variation Measurement: Utilizing genome sequencing.
- Phenotypic Variation Measurement: Employing methods such as measuring blood pressure, genetic diseases, etc.
- Statistical Analysis: Implementing advanced statistical methods to quantify associations and validate findings.
Key Definitions:
- Phenotype: Observable traits or characteristics influenced by genetics and environment.
- Genotype: The genetic constitution of an individual organism.
- Heritability: The extent to which genetic factors account for variation in a trait, often expressed as a percentage.

Mendelian diseases are simpler genetic disorders, characterized by:
- A single gene mutation causing the disease with high penetrance (e.g., Down syndrome, Huntington's disease, sickle cell anemia).
Complex disorders (e.g., heart disease, diabetes) involve many genes and require analysis through GWAS due to their multifactorial nature.

Early Genetic Research:
- Mendel's work laid the foundation for understanding inheritance patterns.
- Identification of genes linked to specific traits, improved by Watson and Crick's discovery of DNA structure (1953).
Progression of Genetic Research:
- Significant advances occurred from the 1960s to the 1990s, including mapping the cystic fibrosis gene (1989).
- The initiation of the Human Genome Project (1990) represented a pivotal point in genetic research.

Definition and Importance of GWAS:
- Aims to find genetic variants behind common diseases by studying large populations rather than small family groups.
- Population-Based Studies: Requires thousands of subjects to identify genetic influences on complex diseases.
Odds Ratios:
- A statistical measure used to determine how likely it is that a certain allele contributes to a condition, often relating to risk factors for disease.
Next Generation Sequencing: Modern technologies allow the production of vast amounts of genetic data quickly and at a low cost, enhancing GWAS capabilities.
Key Concepts:
- Linkage Disequilibrium: Nonrandom association between alleles at different loci, suggesting they are inherited together more often than expected by chance.
- Haplotype: Combination of alleles at adjacent locations on a chromosome inherited together (e.g., Y chromosome haplotype).

GWAS have uncovered many genetic variants associated with diseases but often these variants explain a small proportion of related traits and diseases, leading to the concept of 'missing heritability.'
Statistical Considerations:
- Importance of quality data management and understanding confounding factors (e.g., population stratification).
- Use of appropriate statistical methods (e.g., Bonferroni correction) to account for multiple comparisons when analyzing data.

GWAS continues to evolve and provide insights into complex genetic architectures, despite the majority of genetic variation for many diseases remaining unexplained.
Future research must address the complexities in gene interactions, and continue refining methodology for better accuracy in genetic association studies.

The discussion will now shift towards pharmacogenomics, examining how genetic information influences individual responses to drugs and treatments, enhancing the personalization of medical therapies.